These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10919031)

  • 21. Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020.
    Cornett WR; McCall LM; Petersen RP; Ross MI; Briele HA; Noyes RD; Sussman JJ; Kraybill WG; Kane JM; Alexander HR; Lee JE; Mansfield PF; Pingpank JF; Winchester DJ; White RL; Chadaram V; Herndon JE; Fraker DL; Tyler DS;
    J Clin Oncol; 2006 Sep; 24(25):4196-201. PubMed ID: 16943537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Melphalan monitoring during hyperthermic perfusion of isolated limb for melanoma: pharmacokinetic study and 99mTc-albumin microcolloid technique.
    Cattel L; Buffa E; De Simone M; Cesana P; Novello S; Dosio F; Ceruti M
    Anticancer Res; 2001; 21(3C):2243-8. PubMed ID: 11501854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of isolated lung perfusion with melphalan for resectable pulmonary metastases, a phase I and extension trial.
    Grootenboers MJ; Hendriks JM; van Boven WJ; Knibbe CA; van Putte B; Stockman B; De Bruijn E; Vermorken JB; Van Schil PE; Schramel FM
    J Surg Oncol; 2007 Dec; 96(7):583-9. PubMed ID: 17999399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endovascular isolated hepatic perfusion under pneumoperitoneum.
    Christoforidis D; Antonescu C; Horisberger J; Kosinski M; Mosimann F; Martinet O
    Eur J Surg Oncol; 2006 Feb; 32(1):113-20. PubMed ID: 16289717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The past decade of experience with isolated hepatic perfusion.
    Grover A; Alexander HR
    Oncologist; 2004; 9(6):653-64. PubMed ID: 15561809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolated lung perfusion with melphalan for resectable lung metastases: a phase I clinical trial.
    Hendriks JM; Grootenboers MJ; Schramel FM; van Boven WJ; Stockman B; Seldenrijk CA; ten Broecke P; Knibbe CA; Slee P; De Bruijn E; Vlaeminck R; Heeren J; Vermorken JB; van Putte B; Romijn S; Van Marck E; Van Schil PE
    Ann Thorac Surg; 2004 Dec; 78(6):1919-26; discussion 1926-7. PubMed ID: 15561001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Balloon catheter hypoxic abdominal and pelvic perfusion with tumour necrosis factor-alpha, Melphalan and Mitomycin C: a pharmacokinetic study in pigs.
    van IJken MG; de Bruijn EA; ten Hagen TL; de Boeck G; van Eijck CH; Eggermont AM
    Eur J Surg Oncol; 2004 Aug; 30(6):699-707. PubMed ID: 15256247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Regional isolated perfusion: also applicable in elderly patients].
    Noorda EM; Vrouenraets BC; Nieweg OE; Kroon BB
    Ned Tijdschr Geneeskd; 2003 Mar; 147(12):529-33. PubMed ID: 12693077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolated limb perfusions with tumor necrosis factor and melphalan for locally recurrent soft tissue sarcoma in previously irradiated limbs.
    Lans TE; Grünhagen DJ; de Wilt JH; van Geel AN; Eggermont AM
    Ann Surg Oncol; 2005 May; 12(5):406-11. PubMed ID: 15915375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolated lung perfusion with melphalan: pharmacokinetics and toxicity in a pig model.
    van der Elst A; Oosterling SJ; Paul MA; Vonk AM; Sparidans RW; van der Sijp JR
    J Surg Oncol; 2006 Apr; 93(5):410-6. PubMed ID: 16550578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolated limb perfusion with melphalan and tumor necrosis factor alpha for advanced melanoma and soft-tissue sarcoma.
    Hayes AJ; Neuhaus SJ; Clark MA; Thomas JM
    Ann Surg Oncol; 2007 Jan; 14(1):230-8. PubMed ID: 17066234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolated hepatic perfusion for the treatment of colorectal metastases confined to the liver: recent trends and perspectives.
    Rothbarth J; Tollenaar RA; Schellens JH; Nortier JW; Kool LJ; Kuppen PJ; Mulder GJ; van de Velde CJ
    Eur J Cancer; 2004 Aug; 40(12):1812-24. PubMed ID: 15288282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolated hepatic perfusion: a regional therapy for liver cancer.
    Yang ZW; Xu GL
    Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):12-6. PubMed ID: 14969830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A phase II trial of isolated limb infusion with melphalan and dactinomycin for regional melanoma and soft tissue sarcoma of the extremity.
    Brady MS; Brown K; Patel A; Fisher C; Marx W
    Ann Surg Oncol; 2006 Aug; 13(8):1123-9. PubMed ID: 16791448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Repeat isolated limb perfusion with TNFalpha and melphalan for recurrent limb melanoma after failure of previous perfusion.
    Noorda EM; Vrouenraets BC; Nieweg OE; van Geel AN; Eggermont AM; Kroon BB
    Eur J Surg Oncol; 2006 Apr; 32(3):318-24. PubMed ID: 16412605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolated limb perfusion with melphalan for melanoma.
    Nieweg OE; Kroon BB
    J Surg Oncol; 2014 Mar; 109(4):332-7. PubMed ID: 24421252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pelvic perfusion for localy advanced tumors].
    Bonvalot S; Muret J; Debaere T
    Bull Cancer; 2009 Jan; 96(1):103-9. PubMed ID: 19211365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stop-flow perfusion with mitomycin-C as locoregional approach in the treatment of large-unresectable liver metastases.
    Gadaleta C; Catino A; Mattioli V
    In Vivo; 2006; 20(6A):769-71. PubMed ID: 17203765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolated limb perfusion with tumor necrosis factor-alpha and melphalan for patients with unresectable soft tissue sarcoma of the extremities.
    Noorda EM; Vrouenraets BC; Nieweg OE; van Coevorden F; van Slooten GW; Kroon BB
    Cancer; 2003 Oct; 98(7):1483-90. PubMed ID: 14508836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperthermic isolated limb perfusion with tumor necrosis factor is a useful therapy for advanced melanoma of the limbs.
    Lejeune FJ; Eggermont AM
    J Clin Oncol; 2007 Apr; 25(11):1449-50; author reply 1450-1. PubMed ID: 17416870
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.